1.
不同临床分期乳腺癌患者的血液学参数
Hematological parameters of breast cancer patients in different clinical stages (Mean±SD)
| Group parameter | Normal (n=47) | ⅠA (n=15) | ⅡA (n=11) | ⅡB (n=15) | ⅢA (n=6) | ⅢC (n=5) |
| *P < 0.05, **P < 0.01, compared with normal group. WBC: White blood cells; NEUT: Neutrophils; LYMPH: Lymphocyte; EO: Eosinophils; BASO: Basophils; Total GC: Total granulocytes; NLR: Neutrophil lymphocyte ratio. | ||||||
| WBC (109/L) | 6.33±2.00 | 6.47±1.99 | 5.45±1.39 | 7.93±4.11* | 7.08±1.38 | 6.36±0.72 |
| NEUT (109/L) | 3.88±1.70 | 4.24±1.55 | 3.52±1.38 | 5.97±4.26** | 5.20±1.53 | 4.14±1.05 |
| LYMPH (109/L) | 1.88±0.53 | 1.73±0.70 | 1.49±0.60* | 1.51±0.59* | 1.53±0.64 | 1.76±0.49 |
| LYMPH % | 0.31±0.07 | 0.27±0.09 | 0.28±0.09 | 0.23±0.12** | 0.22±0.08* | 0.28±0.09 |
| EO (109/L) | 0.126±0.104 | 0.085±0.107 | 0.054±0.037* | 0.041±0.043** | 0.042±0.039* | 0.060±0.045* |
| EO % | 0.022±0.017 | 0.015±0.021 | 0.010±0.006** | 0.006±0.006** | 0.005±0.004** | 0.009±0.006** |
| BASO (109/L) | 0.028±0.017 | 0.025±0.011 | 0.025±0.010 | 0.023±0.013 | 0.030±0.010 | 0.026±0.009 |
| BASO % | 0.005±0.005 | 0.004±0.002 | 0.005±0.002 | 0.003±0.001 | 0.004±0.000 | 0.004±0.001 |
| Total GC | 4.04±1.70 | 4.35±1.51 | 3.60±1.37 | 6.03±4.25** | 5.21±1.39 | 4.23±1.08 |
| GC % | 0.62±0.08 | 0.67±0.09 | 0.65±0.10 | 0.72±0.13** | 0.73±0.09** | 0.66±0.10 |
| NLR | 2.15±1.00 | 2.73±1.18 | 2.71±1.53 | 5.71±7.99** | 3.87±1.80 | 2.68±1.59 |